Simcere and Boehringer Ingelheim Enter €1.05 Billion Licensing and Collaboration Agreement for Preclinical IBD Treatment

Sidley has advised Simcere Pharmaceutical Group Ltd. on the deal. Simcere Pharmaceutical Group Ltd. has entered into a licensing and collaboration agreement with Boehringer Ingelheim valued…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here